ClinicalTrials.gg
CompletedNCT02548156Updated Jan 18, 2017Results posted

Intra Oral Kinetics of Fluoride Containing Dentifrices

An interventional study of Test Dentifrice and Reference Dentifrice in Tooth Erosion, sponsored by GlaxoSmithKline. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-01-18.

Sponsored by GlaxoSmithKline · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
29
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The aim of this study is to assess the impact of formulation differences on fluoride retention clearance with US levels of fluoride (1150 ppm of fluoride) by evaluating and comparing between treatments the concentrations of fluoride and calcium ions in saliva over 60 minutes after a single brushing with US marketed fluoridated dentifrices and following a dietary acid challenge post 60 minutes of brushing with study treatment.

02

Conditions studied

  • Tooth Erosion

Browse trials for

03

In context

Tooth Erosion

47 studies on the registry are indexed under Tooth Erosion; 7 are open to participants now.

This study's enrollment of 29 is below the median of 33 across 33 interventional studies indexed under Tooth Erosion.

Browse Tooth Erosion studies →

Lead sponsor

GlaxoSmithKline is the lead sponsor of 3,650 studies on the registry; 118 are open to participants now.

Of its 264 completed or terminated interventional studies of FDA-regulated products, 241 (91%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Demonstrates understanding of the study procedures, restrictions and willingness to participate as evidenced by voluntary written and has received a signed and dated copy of the informed consent form
  • Aged 18-65 years
  • Understands and is willing, able and likely to comply with all study procedures and restrictions
  • Good general and mental health with, in the opinion of the investigator or medically qualified designee:

    1. No and relevant abnormalities of medical history or oral examination
    2. Absence of any condition that would impact on the participant's safety or well being or affect the individual's ability to understand and follow study procedures and requirements
  • A minimum of 20 permanent natural teeth
  • A gum-base stimulated whole saliva flow rate ≥ 0.8 mL/min and an unstimulated whole saliva flow rate ≥ 0.5 mL/min.

Exclusion criteria

Exclusion Criteria:

  • Pregnant or breast feeding women
  • Presence of chronic debilitating disease.
  • Any condition that causes xerostomia as determined by the Investigator.
  • Evidence of untreated caries.
  • Gross periodontal disease.
  • Tongue or lip piercing or presence of dental implants. Professional tooth cleaning or dental treatment during study. Oral surgery or extraction within 6 weeks of the screening visit.
  • Self reported oral symptoms including lesions, sores or inflammation
  • Known or suspected intolerance or to the study materials (or closely related compounds) or any of their stated ingredients
  • Currently taking antibiotics or have taken antibiotics within 2 weeks of the screening visit
  • Any medication that could affect salivary flow or cause xerostomia as determined by the Investigator
  • Use of multivitamins, calcium supplements and or fluoride supplements within 7 days of treatment phase
  • Participant unwilling to abstain from smoking for at least 4 hours on the day of each test visit
  • Recent history (within the last year) of alcohol or other substance abuse.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
29 participants (actual)

Study arms

  • Other
    Test dentifrice

    1.5g (± 0.05g) of Test dentifrice followed by 10mL of de-ionised water rinse, then 10 mL orange juice rinse

    Other: Test Dentifrice · Other: Orange Juice · Other: De-ionised water

  • Other
    Reference dentifrice

    1.5g (± 0.05g) of Reference dentifrice followed by 10mL of de-ionised water rinse, then 10 mL water rinse

    Other: Reference Dentifrice · Other: De-ionised water

  • Other
    Comparator dentifrice

    1.5g (± 0.05g) of Comparator dentifrice followed by 10mL of de-ionised water rinse, then 10 mL orange juice rinse

    Other: Comparator Dentifrice · Other: Orange Juice · Other: De-ionised water

Interventions

  • OtherTest Dentifrice

    Marketed dentifrice containing 1150ppm fluoride and 5% w/w KNO3

  • OtherReference Dentifrice

    Marketed dentifrice containing 1150ppm fluoride and 5% w/w KNO3

  • OtherComparator Dentifrice

    Marketed dentifrice containing 1150ppm fluoride and 5% w/w KNO3

  • OtherOrange Juice

    Teeth will be rinsed with orange juice followed by rinsing with de-ionised water in test dentifrice and comparator dentifrice arms.

  • OtherDe-ionised water

    Teeth will be rinsed with de-ionised water followed by reference dentifrice and followed by rinsing with orange juice in test dentifrice and comparator dentifrice arms.

06

What researchers measure

Primary outcomes

  1. Concentrations of Fluoride Ions in Saliva 60 Minutes Post Brushing Prior to Administration of the Orange Juice or De-ionised Water Rinse

    Concentration of fluoride ions in saliva at 60 minutes after a single brushing with a fluoride dentifrice prior to rinsing with either de-ionised (DI) water or orange juice (OJ). Descriptive data is presented as least square (LS) mean and standard error (SE). SE for Fluoride is the SE of the raw mean.

    Time frame: 60 minutes

Secondary outcomes

  1. Concentrations of Fluoride and Calcium Ions in Saliva Post Brushing Prior to Administration of Orange Juice or De-ionised Water Rinse

    Concentration of fluoride and calcium ions in saliva at baseline, 1, 5, 10, 15, 30 and 60 minutes (for calcium only) after a single brushing with a fluoride dentifrice

    Time frame: up to 60 minutes

  2. Concentrations of Fluoride and Calcium Ions in Saliva Following Administration of the Orange Juice or De-ionised Water Rinse

    Concentration of fluoride and calcium ions in saliva following a rinse with either de ionised water or OJ 60 minutes after a single brushing with a fluoride dentifrice

    Time frame: 60 minutes

  3. Concentrations of Fluoride and Calcium Ions in the Initial Expectorate, De-ionised Water Rinse Post Brushing Expectorate, and 60 Minutes Post Brushing Following Administration of Orange Juice or De-ionised Water Rinse

    Concentration of fluoride and calcium ions in the initial expectorate, de-ionized water rinse post brushing expectorate, and 60 minutes post brushing following administration of orange juice or de-ionised water rinse

    Time frame: up to 60 minutes

07

Results

Posted Jul 27, 2016

Participant flow

Participants were recruited at one Centre United Kingdom.

Period 1
Participant flow — Period 1
MilestoneSequence 1: Test/Comparator/Reference: DentifriceSequence 2: Test/Reference/Comparator: DentifriceSequence 3: Comparator/Test/Reference: DentifriceSequence 4: Comparator/Reference/Test: DentifriceSequence 5: Reference/Test/Comparator: DentifriceSequence 6: Reference/Comparator/Test: Dentifrice
Started554555
Completed554555
Not completed000000
Washout Period 1
Participant flow — Washout Period 1
MilestoneSequence 1: Test/Comparator/Reference: DentifriceSequence 2: Test/Reference/Comparator: DentifriceSequence 3: Comparator/Test/Reference: DentifriceSequence 4: Comparator/Reference/Test: DentifriceSequence 5: Reference/Test/Comparator: DentifriceSequence 6: Reference/Comparator/Test: Dentifrice
Started554555
Completed554545
Not completed000010
Withdrew: Lost to follow-up000010
Period 2
Participant flow — Period 2
MilestoneSequence 1: Test/Comparator/Reference: DentifriceSequence 2: Test/Reference/Comparator: DentifriceSequence 3: Comparator/Test/Reference: DentifriceSequence 4: Comparator/Reference/Test: DentifriceSequence 5: Reference/Test/Comparator: DentifriceSequence 6: Reference/Comparator/Test: Dentifrice
Started554545
Completed554545
Not completed000000
Washout Period 2
Participant flow — Washout Period 2
MilestoneSequence 1: Test/Comparator/Reference: DentifriceSequence 2: Test/Reference/Comparator: DentifriceSequence 3: Comparator/Test/Reference: DentifriceSequence 4: Comparator/Reference/Test: DentifriceSequence 5: Reference/Test/Comparator: DentifriceSequence 6: Reference/Comparator/Test: Dentifrice
Started554545
Completed554545
Not completed000000
Period 3
Participant flow — Period 3
MilestoneSequence 1: Test/Comparator/Reference: DentifriceSequence 2: Test/Reference/Comparator: DentifriceSequence 3: Comparator/Test/Reference: DentifriceSequence 4: Comparator/Reference/Test: DentifriceSequence 5: Reference/Test/Comparator: DentifriceSequence 6: Reference/Comparator/Test: Dentifrice
Started554545
Completed554545
Not completed000000

Outcome measures

PrimaryConcentrations of Fluoride Ions in Saliva 60 Minutes Post Brushing Prior to Administration of the Orange Juice or De-ionised Water Rinse

Concentration of fluoride ions in saliva at 60 minutes after a single brushing with a fluoride dentifrice prior to rinsing with either de-ionised (DI) water or orange juice (OJ). Descriptive data is presented as least square (LS) mean and standard error (SE). SE for Fluoride is the SE of the raw mean.

Time frame:
60 minutes
Reported as:
Least squares mean · parts per million(ppm)
Concentrations of Fluoride Ions in Saliva 60 Minutes Post Brushing Prior to Administration of the Orange Juice or De-ionised Water Rinse
parts per million(ppm)Test DentifriceReference DentifriceComparator Dentifrice
Concentrations of Fluoride Ions in Saliva 60 Minutes Post Brushing Prior to Administration of the Orange Juice or De-ionised Water Rinse0.23 ± 0.04690.23 ± 0.04300.15 ± 0.0485
Statistical analysis
  • Test Dentifrice vs Reference Dentifrice vs Comparator Dentifrice · ANCOVA · p = <0.0001 (From ANCOVA of log transformed data: subject (random), treatment (fixed) and period (fixed) as factors, participant-level baseline and period-level baseline minus participant-level baseline as covariates.) · Ratio of ls mean: 1.52Treatment difference from ANCOVA of log transformed data. This therefore represents the ratio of the first named treatment to the second named treatment. A ratio \>1 favors the first named treatment.
SecondaryConcentrations of Fluoride and Calcium Ions in Saliva Post Brushing Prior to Administration of Orange Juice or De-ionised Water Rinse

Concentration of fluoride and calcium ions in saliva at baseline, 1, 5, 10, 15, 30 and 60 minutes (for calcium only) after a single brushing with a fluoride dentifrice

Time frame:
up to 60 minutes
Reported as:
Mean · ppm
Concentrations of Fluoride and Calcium Ions in Saliva Post Brushing Prior to Administration of Orange Juice or De-ionised Water Rinse
ppmTest DentifriceReference DentifriceComparator Dentifrice
Fluoride: At baseline (n=26, 28, 26)0.045 ± 0.01250.032 ± 0.00840.031 ± 0.0072
Fluoride: At 1 minute (n=27, 28, 26)8.775 ± 0.83018.794 ± 1.05627.630 ± 0.7497
Fluoride: At 5 minute (n=27, 27, 27)3.881 ± 0.41154.132 ± 0.47593.492 ± 0.4664
Fluoride: At 10 minute (n=26, 26, 26)1.831 ± 0.19801.951 ± 0.26541.476 ± 0.1524
Fluoride: At 15 minute (n=27, 27, 26)1.346 ± 0.18271.188 ± 0.15500.942 ± 0.1432
Fluoride: At 30 minute (n=26, 27, 27)0.656 ± 0.10650.600 ± 0.08100.479 ± 0.0723
Calcium: At Baseline (n=26, 25, 22)29.749 ± 0.942828.357 ± 1.016228.661 ± 1.0657
Calcium: At 1 minute (n=23, 28, 25)28.300 ± 1.517127.217 ± 1.068914.931 ± 1.0999
Calcium: At 5 minute (n=16, 17, 22)27.818 ± 1.374326.070 ± 1.463817.227 ± 0.9170
Calcium: At 10 minute (n=16, 16, 21)27.472 ± 1.006125.672 ± 1.194420.133 ± 1.0395
Calcium: At 15 minute (n=18, 20, 20)28.319 ± 1.078327.227 ± 0.865623.761 ± 1.2803
Calcium: At 30 minute (n=17, 18, 20)28.650 ± 1.072527.323 ± 1.032524.196 ± 1.3196
Calcium: At 60 minute (n=23, 20, 22)28.198 ± 1.007327.094 ± 1.056027.104 ± 1.3777
SecondaryConcentrations of Fluoride and Calcium Ions in Saliva Following Administration of the Orange Juice or De-ionised Water Rinse

Concentration of fluoride and calcium ions in saliva following a rinse with either de ionised water or OJ 60 minutes after a single brushing with a fluoride dentifrice

Time frame:
60 minutes
Reported as:
Least squares mean · ppm
Concentrations of Fluoride and Calcium Ions in Saliva Following Administration of the Orange Juice or De-ionised Water Rinse
ppmTest DentifriceReference DentifriceComparator Dentifrice
Fluoride Ion concentration(n=27, 28, 27)0.349 ± 0.03490.169 ± 0.11040.277 ± 0.1601
Calcium Ion concentration (n=26, 22, 25)15.015 ± 4.335527.263 ± 4.711314.805 ± 4.0473
SecondaryConcentrations of Fluoride and Calcium Ions in the Initial Expectorate, De-ionised Water Rinse Post Brushing Expectorate, and 60 Minutes Post Brushing Following Administration of Orange Juice or De-ionised Water Rinse

Concentration of fluoride and calcium ions in the initial expectorate, de-ionized water rinse post brushing expectorate, and 60 minutes post brushing following administration of orange juice or de-ionised water rinse

Time frame:
up to 60 minutes
Reported as:
Mean · ppm
Concentrations of Fluoride and Calcium Ions in the Initial Expectorate, De-ionised Water Rinse Post Brushing Expectorate, and 60 Minutes Post Brushing Following Administration of Orange Juice or De-ionised Water Rinse
ppmTest DentifriceReference DentifriceComparator Dentifrice
Fluoride: In initial expectorate178.522 ± 61.1593168.728 ± 54.3780164.708 ± 54.2632
Fluoride: Post-Brushing De-Ionised Water Rinse Ex8.377 ± 4.23467.721 ± 4.17217.443 ± 3.4546
Fluoride: 60 Minutes Post Brushing0.166 ± 0.06090.046 ± 0.03700.135 ± 0.0563
Calcium: In initial expectorate17.096 ± 4.786417.467 ± 4.12412.500 ± 0.0000
Calcium: Post-Brushing De-Ionised Water Rinse Ex4.959 ± 2.27124.438 ± 2.21412.500 ± 0.0000
Calcium: 60 Minutes Post Brushing96.165 ± 9.23574.600 ± 2.050799.189 ± 17.2771

Adverse events

Non-serious events are listed at a 1% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Test Dentifrice—0/28 (0%)8/28 (28.6%)
Reference Dentifrice—0/29 (0%)3/29 (10.3%)
Comparator Dentifrice—0/28 (0%)5/28 (17.9%)
Most frequent other events
Showing 10 of 13
Most frequent other events
EventTest DentifriceReference DentifriceComparator Dentifrice
Oral herpesInfections and infestations0/280/292/28
Mouth injuryInjury, poisoning and procedural complications2/280/291/28
Chapped LipsGastrointestinal disorders1/280/290/28
NauseaGastrointestinal disorders1/280/290/28
Device failureGeneral disorders1/280/290/28
Medical device complicationGeneral disorders1/280/290/28
InfluenzaInfections and infestations0/280/291/28
RhinitisInfections and infestations0/280/291/28
HeadacheNervous system disorders1/280/291/28
Oropharyngeal PainRespiratory, thoracic and mediastinal disorders1/280/290/28

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Overall Study
Mean34.8 ± 9.12
Gender
Gender(Participants)Overall Study
Female23
Male6
08

Study locations

1 site
  • GSK Investigational Site
    Ellesmere Port, Cheshire CH65 4BW, United Kingdom
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 18, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02548156
Lead sponsor
GlaxoSmithKline
Responsible party
Sponsor
First posted
Sep 14, 2015
Start date
Sep 2015
Primary completion
Oct 2015
Completion
Oct 2015
Results posted
Jul 27, 2016
Last update
Jan 18, 2017

Study contacts

GSK Clinical Trials
study director · GlaxoSmithKline

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion